Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/31757| Title: | A Multi-Center Real-World Experience of IMpower150 in Oncogene Driven Tumors and CNS Metastases. | Austin Authors: | Itchins, Malinda;Ainsworth, Hannah;Alexander, Marliese;Dean, Samantha;Dharmaraj, Devi;Pavlakis, Nick;Clarke, Stephen J;Brown, Chris;Torres, Javier;Saqib, Ayesha;Ladwa, Rahul;O'Byrne, Kenneth;Moore, Melissa;Yip, Po Yee;Solomon, Ben;John, Tom ;Kao, Steven;Mitchell, Paul L R ;Parakh, Sagun | Affiliation: | Medical Oncology, Royal North Shore Hospital, The University of Sydney, St Leonards, New South Wales, Australia. Medical Oncology, Royal North Shore Hospital, The University of Sydney, St Leonards, New South Wales, Australia. Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Victoria, Australia. Medical Oncology Medical Oncology, Austin Health, La Trobe University, Heidelberg, Victoria, Australia. Medical Oncology, Royal North Shore Hospital, The University of Sydney, St Leonards, New South Wales, Australia. NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia. Goulburn Valley Health, Shepparton, Victoria, Australia. Epworth Healthcare, Richmond, Australia. Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia. St. Vincent's Hospital, Fitzroy, Victoria, Australia. Medical Oncology, Macarthur Cancer Therapy Centre, Campbelltown Hospital, Western Sydney University, Campbelltown, New South Wales, Australia. Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Victoria, Australia. Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Victoria, Australia. Medical Oncology, Chris O'Brien Lifehouse, The University of Sydney, Camperdown, New South Wales, Australia. |
Issue Date: | Dec-2022 | Date: | 2022 | Publication information: | Clinical Lung Cancer 2022; 23(8) | Abstract: | There are limited real world data on the IMpower150 regimen in oncogene driven tumors and central nervous system metastases; this study aims to address this gap. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/31757 | DOI: | 10.1016/j.cllc.2022.07.016 | ORCID: | Journal: | Clinical Lung Cancer | Start page: | 702 | End page: | 708 | PubMed URL: | 36030187 | ISSN: | 1938-0690 | Type: | Journal Article | Subjects: | Efficacy IMPower150 Real world Toxicity Carcinoma, Non-Small-Cell Lung/drug therapy Carcinoma, Non-Small-Cell Lung/genetics ErbB Receptors/genetics Lung Neoplasms/drug therapy Lung Neoplasms/genetics Central Nervous System Neoplasms/drug therapy Central Nervous System Neoplasms/genetics Mutation/genetics Brain Neoplasms/drug therapy Brain Neoplasms/genetics Brain Neoplasms/pathology Neoplasms, Second Primary/genetics |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.